FGF23 and chronic kidney disease: Throughout these hormonal alterations, serum phosphate levels gradually increase and by end-stage renal disease (ESRD), ultimately culminate in overt hyperphosphatemia due to renal resistance to FGF23′s actions on impaired kidneys [115,139,147].